Pyloric Brunner’s gland hamartoma with atypical hyperplasia

Brunner’s gland hamartoma (BGH) is an extremely rare benign digestive tumor, \ud generally located in the duodenal bulb. We report the case of a 51-year-old \ud asymptomatic man with a large pedunculated BGH arising from the pylorus. It \ud was successfully removed en bloc by endoscopic resection

\textsc{MaGe} - a {\sc Geant4}-based Monte Carlo Application Framework for Low-background Germanium Experiments

We describe a physics simulation software framework, MAGE, that is based on the GEANT4 simulation toolkit. MAGE is used to simulate the response of ultra-low radioactive background radiation detectors to ionizing radiation, specifically the MAJORANA and GERDA neutrinoless double-beta decay experiments. MAJORANA and GERDA use high-purity germanium detectors to search for the neutrinoless double-beta decay of 76Ge, and MAGE is jointly developed between these two collaborations. The MAGE framework contains the geometry models of common objects, prototypes, test stands, and the actual experiments. It also implements customized event generators, GEANT4 physics lists, and output formats. All of these features are available as class libraries that are typically compiled into a single executable. The user selects the particular experimental setup implementation at run-time via macros. The combination of all these common classes into one framework reduces duplication of efforts, eases comparison between simulated data and experiment, and simplifies the addition of new detectors to be simulated. This paper focuses on the software framework, custom event generators, and physics lists.Comment: 12 pages, 6 figure

MaGe-a Geant4-Based Monte Carlo Application Framework for Low-Background Germanium Experiments

We describe a physics simulation software framework, MAGE, that is based on the GEANT4 simulation toolkit. MAGE is used to simulate the response of ultra-low radioactive background radiation detectors to ionizing radiation, specifically the MAJORANA and GERDA neutrinoless double-beta decay experiments. MAJORANA and GERDA use high-purity germanium detectors to search for the neutrinoless double-beta decay of 76Ge, and MAGE is jointly developed between these two collaborations. The MAGE framework contains the geometry models of common objects, prototypes, test stands, and the actual experiments. It also implements customized event generators, GEANT4 physics lists, and output formats. All of these features are available as class libraries that are typically compiled into a single executable. The user selects the particular experimental setup implementation at run-time via macros. The combination of all these common classes into one framework reduces duplication of efforts, eases comparison between simulated data and experiment, and simplifies the addition of new detectors to be simulated. This paper focuses on the software framework, custom event generators, and physics lists

EuReCa ONE—27 Nations, ONE Europe, ONE Registry A prospective one month analysis of out-of-hospital cardiac arrest outcomes in 27 countries in Europe

AbstractIntroductionThe aim of the EuReCa ONE study was to determine the incidence, process, and outcome for out of hospital cardiac arrest (OHCA) throughout Europe.MethodsThis was an international, prospective, multi-centre one-month study. Patients who suffered an OHCA during October 2014 who were attended and/or treated by an Emergency Medical Service (EMS) were eligible for inclusion in the study. Data were extracted from national, regional or local registries.ResultsData on 10,682 confirmed OHCAs from 248 regions in 27 countries, covering an estimated population of 174 million. In 7146 (66%) cases, CPR was started by a bystander or by the EMS. The incidence of CPR attempts ranged from 19.0 to 104.0 per 100,000 population per year. 1735 had ROSC on arrival at hospital (25.2%), Overall, 662/6414 (10.3%) in all cases with CPR attempted survived for at least 30 days or to hospital discharge.ConclusionThe results of EuReCa ONE highlight that OHCA is still a major public health problem accounting for a substantial number of deaths in Europe.EuReCa ONE very clearly demonstrates marked differences in the processes for data collection and reported outcomes following OHCA all over Europe. Using these data and analyses, different countries, regions, systems, and concepts can benchmark themselves and may learn from each other to further improve survival following one of our major health care events